Kuypers K P C, Samyn N, Ramaekers J G
Experimental Psychopharmacology Unit, Department of Neurocognition, Faculty of Psychology, Maastricht University, Maastricht, The Netherlands.
Psychopharmacology (Berl). 2006 Sep;187(4):467-75. doi: 10.1007/s00213-006-0434-z. Epub 2006 Jul 8.
The party drug ecstasy is frequently used in combination with other drugs like marihuana and alcohol. In addition, a substantial proportion of the MDMA users has claimed to drive a car when under the influence of MDMA and/or other drugs.
To assess the effects of MDMA and alcohol, combined and alone, on actual driving performance and laboratory tasks related to driving.
Eighteen healthy subjects participated in a double-blind, placebo-controlled, six-way cross-over study. Treatments consisted of MDMA 0, 75, and 100 mg with and without alcohol, aiming at 0.06 mg/ml BAC. Laboratory tests (critical tracking task, object movement estimation task) were conducted between 1.5 and 2 h postdrug (0.5 and 1 h postalcohol). Actual driving tests (road tracking test, car-following test) were conducted between 3 and 5 h postdrug (2 and 4 h postalcohol). Subjects completed the addiction research center inventory (ARCI) and rated their driving quality and mental effort during driving.
Alcohol alone impaired critical tracking performance, as well as a number of actual driving performance parameters [i.e., standard deviation of lateral position (SDLP), brake reaction time, and coherence]. MDMA alone reduced SDLP and standard deviation of speed. MDMA significantly moderated alcohol induced impairment of road tracking performance but did not affect alcohol impairments of car-following and laboratory task performance. Subjective data seemed to support objective data.
MDMA moderated the impairing effects of a low dose of alcohol on road tracking performance but it could not overcome alcohol-induced impairment on other aspects of driving behavior or driving related performance.
派对毒品摇头丸经常与大麻和酒精等其他毒品混合使用。此外,相当一部分摇头丸使用者声称在受摇头丸和/或其他毒品影响时开车。
评估摇头丸和酒精单独及联合使用对实际驾驶性能和与驾驶相关的实验室任务的影响。
18名健康受试者参与了一项双盲、安慰剂对照、六向交叉研究。治疗包括0、75和100毫克摇头丸,有或没有酒精,目标血液酒精浓度(BAC)为0.06毫克/毫升。在用药后1.5至2小时(饮酒后0.5至1小时)进行实验室测试(临界跟踪任务、物体运动估计任务)。在用药后3至5小时(饮酒后2至4小时)进行实际驾驶测试(道路跟踪测试、跟车测试)。受试者完成成瘾研究中心量表(ARCI),并对驾驶过程中的驾驶质量和精神努力程度进行评分。
单独使用酒精会损害临界跟踪性能以及一些实际驾驶性能参数[即横向位置标准差(SDLP)、制动反应时间和连贯性]。单独使用摇头丸会降低SDLP和速度标准差。摇头丸显著减轻了酒精对道路跟踪性能的损害,但不影响酒精对跟车和实验室任务性能的损害。主观数据似乎支持客观数据。
摇头丸减轻了低剂量酒精对道路跟踪性能的损害,但无法克服酒精对驾驶行为其他方面或与驾驶相关性能的损害。